Expert Discusses Urothelial Carcinoma's Newest Agent
BY Shannon Connelly
Imfinzi (durvalumab) may change the treatment paradigm for some patients with urothelial carcinoma.
Pre-Surgical Gemcitabine Plus Cisplatin Benefits Bladder Cancer
BY Ariela Katz
When used as a neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC), split-dose of gemcitabine and cisplatin has a beneficial response and a high safety profile, according to a study presented at the 2017 American Urological Association Annual Meeting.
Combined Modality Treatment May Be OK as First Course of Treatment for Muscle-Invasive Bladder Cancer
BY Katie Kosko
Combined modality treatment (CMT) could be considered a first course of treatment for patients with muscle-invasive bladder cancer, according to the authors of a recent study published in the International Journal of Radiation Oncology.
Drug Combination Is Effective in Urothelial Carcinoma
BY Jason M. Broderick
When combined with the IDO1 inhibitor epacadostat, Keytruda (pembrolizumab), a PD-1 inhibitor, resulted in an overall response rate (ORR) of 35 percent in patients with advanced urothelial carcinoma, according to results from the phase 1/2 ECHO-202/KEYNOTE-037 trial.
Combination Improves Progression-Free Survival in Urothelial Carcinoma
BY Jason Harris
According to results from the phase 3 RANGE trial, the addition of Cyramza (ramucirumab) to docetaxel resulted in improved progression-free survival for patients with previously treated locally advanced or unresectable or metastatic urothelial carcinoma.
Marilu Henner: Acknowledging Symptoms is the First Stop on the Road to Health
BY Brielle Urciuoli
Actress Marilu Henner spoke with CURE about her husband's journey with cancer and the importance of having the difficult conversations.
Expert Discusses Reducing Recurrence Risk in Bladder Cancer
BY Angelica Welch
Edward Messing, M.D., discusses his recent paper which explored a possible way to reduce recurrence in some patients with bladder cancer.
Electronic Cigarettes May Still Pose Bladder Cancer Risk
BY Allie Casey
Though deemed "safer" than normal cigarettes, electronic cigarettes may still pose a risk for bladder cancer.
Expert Discusses Urothelial Carcinoma Approval
BY Danielle Bucco
Arjun V. Balar, M.D., discusses Keytruda's impact on the treatment of urothelial carcinoma.
FDA Approves Keytruda Approved for Urothelial Carcinoma
BY Jason M. Broderick
Keytruda (pembrolizumab) was granted an approval by the Food and Drug Administration (FDA) to treat some patients with locally advanced or metastatic urothelial carcinoma. 
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Bladder CURE discussion group.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Bladder Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of bladder cancer.
Gallbladder Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of gallbladder cancer.